Crédit Mutuel Innovation is a venture capital firm specializing in seed, start-up and growth capital companies.
Business Model:
Revenue: $0
Employees: 0-0
Address: 28, Avenue de l'Opéra
City: Paris
State: île-de-france
Zip: 75002
Country: FR
Crédit Mutuel Innovation is the evergreen venture capital entity of Crédit Mutuel Equity (€3.5 billion in capital). We invest €1-20M in life science, digital and deeptech companies from seed to growth stages. We help bold and ambitious entrepreneurs to develop their strong growth potential with our worldwide enterprise ecosystem (our 350+ portfolio companies, our abroad subsidiaries, 150+ largest global corporates and the best-in-class experts). Because it takes more than 5 years to build a Unicorn, we invest our own equity and ensure durable partnerships with visionary leaders. Today, the 350 companies in which we have invested generate a cumulative annual turnover of €50bn and create more than 250,000 jobs.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2007 | Endocontrol | Seed Round | 1.5M |
9/2020 | Maria Schools | Seed Round | 2.3M |
5/2012 | Sphering Group | Private Equity Round | 5.1M |
8/2011 | Babymoov Group | Venture Round | 7.5M |
6/2018 | Tricares | Series B | 25.7M |
1/2011 | Polyplus-transfection | Venture Round | 0 |
7/2013 | Lucibel | Venture Round | 2M |
3/2023 | IEVA | Venture Round | 0 |
4/2021 | Solveo Energie | Venture Round | 0 |
9/2014 | Vi Technology | Venture Round | 19.3M |
6/2015 | Exagan | Series A | 0 |
12/2013 | Lucibel | Venture Round | 20.5M |
4/2014 | ENAG S.A.S. | Venture Round | 1.8M |
9/2021 | Ribonexus | Seed Round | 0 |
5/2017 | Societe Paul Marguet | Venture Round | 2.7M |
9/2016 | Sigma Informatique | Venture Round | 6.7M |
1/2014 | Vicomte A | Venture Round | - |
9/2011 | Aplix | Venture Round | - |
10/2017 | Dupont Restauration | Venture Round | - |
4/2022 | Implicity | Series A | 0 |
1/2019 | Antidot | Series A | 6.5M |
7/2013 | Kerlink | Venture Round | 1.9M |
6/2016 | InFlectis BioScience | Series A | 6.8M |
1/2018 | ForCity | Series A | 0 |
11/2014 | Intersec | Series B | 20M |
1/2019 | STIMIO | Seed Round | 1.5M |
11/2017 | Smartrenting | Seed Round | 1.2M |
1/2019 | Diota | Series B | 8M |
7/2020 | Planity | Series A | 0 |
3/2011 | Altrad Group | Venture Round | - |
7/2013 | Coldway SA | Venture Round | - |
1/2016 | Caravane | Private Equity Round | - |
9/2016 | Frénéhard &a; Michaux | Venture Round | 16.3M |
10/2012 | GEOCONCEPT Group | Venture Round | 6.5M |
11/2019 | TISSIUM | Series B | 43.2M |
3/2023 | Glopal | Series A | 0 |
7/2022 | Ganymed Robotics | Series B | 0 |
9/2022 | Tricares | Series C | 0 |
6/2022 | SOLAL Tech | Seed Round | 0 |
5/2023 | Worldia | Series B | 0 |
9/2013 | Exotismes | Venture Round | 2.6M |
9/2020 | Oncomfort | Series A | 0 |
11/2021 | TruTag Technologies | Series D | 0 |
5/2022 | Therapixel | Series B | 0 |
9/2019 | Wizaplace | Venture Round | 14.3M |
1/2002 | Wokup | Venture Round | 11.7M |
7/2016 | Aries Alliance | Venture Round | - |
10/2018 | Universign | Venture Round | 13.9M |
5/2010 | Nanobiotix | Series C | 0 |
6/2020 | Saagie | Series B | 28.1M |
2/2021 | MedinCell | Post-IPO Equity | 36.2M |
3/2016 | Intersec | Series C | 10M |
6/2013 | Groupe AGDA Immobilier | Venture Round | 5.3M |
6/2021 | ADVITOS | Venture Round | 24.3M |
1/2007 | Voluntis | Venture Round | 2.6M |
4/2017 | Training Orchestra | Series A | 5.7M |
10/2012 | e(ye)BRAIN | Series B | 3.3M |
5/2022 | Therapixel | Series B | 0 |
3/2017 | Hemarina | Series C | - |
1/2011 | Antidot | Seed Round | 3.5M |
6/2017 | Menway | Venture Round | 16.9M |
7/2021 | Planity | Series B | 0 |
3/2023 | MentorShow | Series A | 0 |
10/2017 | ROBART | Series B | 7.2M |
2/2015 | Capelle Groupe | Venture Round | 9.1M |
3/2016 | MaaT Pharma | Series A | 11.2M |
9/2018 | iskn | Venture Round | 0 |
7/2020 | AB Tasty | Series C | 0 |
10/2012 | CELESTE | Venture Round | - |
3/2018 | ABF Décisions | Venture Round | 2.4M |
4/2015 | ABEO SAS | Venture Round | - |
12/2013 | Cap Ingelec | Venture Round | - |
2/2020 | MaaT Pharma | Series B | 19.8M |
2/2011 | Groupe JORYF | Venture Round | - |
10/2011 | Alstef | Venture Round | - |
1/2011 | Airtag | Venture Round | 5.5M |
11/2015 | Gabriel boudier | Venture Round | 1.9M |
1/2010 | Endocontrol | Series A | 4.3M |
3/2022 | NEOBRAIN | Series A | 0 |
3/2016 | TISSIUM | Series A | 25.5M |
11/2013 | Universign | Venture Round | 2.3M |
6/2020 | Invenis | Series A | 3.4M |
9/2010 | Kalistick | Series A | 1.3M |
1/2015 | Auxitec Industrie | Venture Round | - |
5/2023 | Worldia | Series B | 0 |
3/2023 | Glopal | Series A | 0 |
3/2023 | MentorShow | Series A | 0 |
3/2023 | IEVA | Venture Round | 0 |
9/2022 | Tricares | Series C | 0 |
7/2022 | Ganymed Robotics | Series B | 0 |
6/2022 | SOLAL Tech | Seed Round | 0 |
5/2022 | Therapixel | Series B | 0 |
4/2022 | Implicity | Series A | 0 |
3/2022 | NEOBRAIN | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|